Davis Polk advised the representatives of the underwriters on KE Holdings’ initial public offering of 106,000,000 American depositary shares, for total proceeds of $2.12 billion. KE…
Davis Polk advised the initial purchasers in connection with a $200 million Regulation S only offering by China South City Holdings Limited of its 11.500% senior notes due 2021.
CSC is a…
Davis Polk advised the initial purchasers in connection with a $200 million Regulation S high-yield offering by KWG Group Holdings Limited of its 5.950% senior notes due 2025.
KWG Group…
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…
Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…
Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 5.950% senior notes due 2025.
Established in 2000…
Davis Polk advised the initial purchasers in a Regulation S offering by Trip.com Group Limited of $500 million aggregate principal amount of 1.500% exchangeable senior notes due 2027…
Davis Polk advised the initial purchasers in connection with the Regulation S offering of $250 million principal amount of 9.000% senior notes due 2021 by RongXingDa Development (BVI)…
Davis Polk advised the initial purchasers in connection with a $170 million Regulation S offering by Golden Wheel Tiandi Holdings Limited of its 14.250% senior notes due 2023.
Golden Wheel…
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…